ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Teva Pharmaceutical (TEVA) Technical (Analysis) Reports Teva Pharmaceutical ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Teva Pharmaceutical (TEVA)

Technical Analysis Report for NYSE stock TEVA Teva Pharmaceutical. Dated: 01 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange

If you are looking for Tomorrow's Movement Predictions for NYSE stock TEVA Teva Pharmaceutical then click here. or read Experts views on Teva Pharmaceutical or Forecast & share price targets of Teva Pharmaceutical

Teva Pharmaceutical Opened at 35.16 and Closed at: 34.95, which is -0.34% of previous session's close. It moved within a range of 34.51 and 35.18
The session was a Bearish session with an average volume of 6629900, which is -142.69% of previous session's volumes.

  • Even though the stock has fallen, but its short term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Golden cross was found 7 days back on mid term averages

Support for tomorrow is 34.4 and resistance for tomorrow is 35.07
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 34.58, 34.21 resistance for tomorrow's hourly charts is 35.25, 35.55

10 Day SMA for Teva Pharmaceutical (TEVA) is 32.47 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Teva Pharmaceutical (TEVA) is 31.71 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Teva Pharmaceutical (TEVA) is 31.35 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 31.8 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Teva Pharmaceutical is 25.91 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Teva Pharmaceutical is at 31.71 and 200 DMA is at 25.91, while 50 DMA and 100 DMA are at 31.35 and 31.8 respectively

Teva Pharmaceutical (TEVA) moving average of 20 SMA is at 31.71 and 20 EMA is at 32.11

Teva Pharmaceutical (TEVA) moving average of 50 SMA is at 31.35 and 50 EMA is at 31.5

Teva Pharmaceutical (TEVA) moving average of 100 SMA is at 31.8 and 100 EMA is at 30.28

Teva Pharmaceutical (TEVA) moving average of 200 SMA is at 25.91 and 200 EMA is at 27.33

Teva Pharmaceutical has performed better than Smith Nephew in short term. Holding Teva Pharmaceutical could be a better choice for now!

Teva Pharmaceutical has performed better than Select Medical in short term. Holding Teva Pharmaceutical could be a better choice for now!

Teva Pharmaceutical has performed better than Abbvie Inc in short term. Holding Teva Pharmaceutical could be a better choice for now!

Avanos Medical has performed better than Teva Pharmaceutical in short term. You could have earned much better returns by investing in Avanos Medical, about 61.11% more returns!

Teva Pharmaceutical has performed better than Cardinal Health in short term. Holding Teva Pharmaceutical could be a better choice for now!

Centene Corporation has performed better than Teva Pharmaceutical in short term. You could have earned much better returns by investing in Centene Corporation, about 33.52% more returns!

Teva Pharmaceutical has performed better than Cvs Health in short term. Holding Teva Pharmaceutical could be a better choice for now!

Teva Pharmaceutical has performed better than Edwards Lifesciences in short term. Holding Teva Pharmaceutical could be a better choice for now!

Humana Inc has performed better than Teva Pharmaceutical in short term. You could have earned much better returns by investing in Humana Inc, about 10.66% more returns!

Teva Pharmaceutical has performed better than Inspire Medical in short term. Holding Teva Pharmaceutical could be a better choice for now!

Teva Pharmaceutical has performed better than Johnson Johnson in short term. Holding Teva Pharmaceutical could be a better choice for now!

Teva Pharmaceutical has performed better than Mednax Inc in short term. Holding Teva Pharmaceutical could be a better choice for now!

Teva Pharmaceutical has performed better than Medtronic Plc in short term. Holding Teva Pharmaceutical could be a better choice for now!

Molina Healthcare has performed better than Teva Pharmaceutical in short term. You could have earned much better returns by investing in Molina Healthcare, about 17.22% more returns!

Novo Nordisk has performed better than Teva Pharmaceutical in short term. You could have earned much better returns by investing in Novo Nordisk, about 2.49% more returns!

Teva Pharmaceutical has performed better than Penumbra Inc in short term. Holding Teva Pharmaceutical could be a better choice for now!

Teva Pharmaceutical Technical analysis of indicators

Price action analysis of Teva Pharmaceutical (TEVA) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Teva Pharmaceutical stock for short term is BUY. Signal strength is Strong and stock is losing momentum.

MACD generated a BUY signal for Teva Pharmaceutical in short term and the buy signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Teva Pharmaceutical Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Teva Pharmaceutical in short term but SELL signal is weak.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Teva Pharmaceutical is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 33.5 and Teva Pharmaceutical TEVA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Teva Pharmaceutical TEVA stock. Volume based technical analysis of Teva Pharmaceutical TEVA stock is negative.

Teva Pharmaceutical Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NYSE stock TEVA Teva Pharmaceutical These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And TEVA Experts View which covers a lot of information including buying and selling signals

TEVA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Teva Pharmaceutical or View Candle Stick Charts here

Chart Teva Pharmaceutical (TEVA)  Technical (Analysis) Reports Teva Pharmaceutical [

Videos related to: Teva Pharmaceutical (TEVA) Technical (Analysis) Reports Teva Pharmaceutical ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Teva Pharmaceutical (TEVA)  Technical (Analysis) Reports Teva Pharmaceutical [

 

Back to top